Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 11 • 04:00PM ET

20.25

-1.32 -6.12 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF IWC ITOT TMSL DFAS DFMC TMED BMED DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	9.98%	Shs Outstand	26.71M	Perf Week	46.95%
Market Cap	540.97M	Forward P/E	-	EPS next Y	-4.03	Insider Trans	-10.85%	Shs Float	24.05M	Perf Month	48.24%
Enterprise Value	445.03M	PEG	-	EPS next Q	-1.03	Inst Own	72.23%	Short Float	23.84%	Perf Quarter	44.54%
Income	-78.26M	P/S	9016.12	EPS this Y	39.41%	Inst Trans	25.13%	Short Ratio	4.71	Perf Half Y	31.32%
Sales	0.06M	P/B	4.51	EPS next Y	-13.95%	ROA	-58.31%	Short Interest	5.73M	Perf YTD	11.51%
Book/sh	4.49	P/C	5.50	EPS next 5Y	14.19%	ROE	-72.43%	52W High	24.27 -16.56%	Perf Year	398.77%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 497.35%	Perf 3Y	-96.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	17.23% 10.04%	Perf 5Y	-99.73%
Dividend TTM	-	EV/Sales	7417.12	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.84	Perf 10Y	-99.82%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	64.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	29.66%	Beta	0.87	Target Price	48.10
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	29.83%	Rel Volume	2.34	Prev Close	21.57
Employees	33	LT Debt/Eq	0.02	Earnings	Mar 23 BMO	SMA200	38.36%	Avg Volume	1.22M	Price	20.25
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	47.48% -	Trades		Volume	2,848,789	Change	-6.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)